Atara Biotherapeutics, Inc. ( ATRA) - Stock Earnings
ATRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.3 million USD | 3.5 million USD |
| 2025Q4 | -3.4 million USD | 1.6 million USD |
| 2026Q1 | -4.1 million USD | 516000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ATRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -276.1 million USD | 8.6 million USD |
| 2024 | -85.4 million USD | 128.9 million USD |
| 2025 | 32.7 million USD | 120.8 million USD |
| 2026 Est. | — | — |
ATRA
Price: $10.07
52 week price:
Earnings Per Share: -1.22 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 783100
Ebitda: -31.4 millionMarket Capitalization: 89.4 million